Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine
- 7 March 2007
- Vol. 25 (20) , 4085-4092
- https://doi.org/10.1016/j.vaccine.2007.02.050
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 DNA Candidate VaccineThe Journal of Infectious Diseases, 2006
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus VectorThe Journal of Infectious Diseases, 2006
- A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical TrialClinical and Vaccine Immunology, 2006
- Human Immunodeficiency Virus Type 1envClones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing AntibodiesJournal of Virology, 2005
- A Human T-Cell Leukemia Virus Type 1 Regulatory Element Enhances the Immunogenicity of Human Immunodeficiency Virus Type 1 DNA Vaccines in Mice and Nonhuman PrimatesJournal of Virology, 2005
- Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA VaccinesJournal of Virology, 2003
- Modifications of the Human Immunodeficiency Virus Envelope Glycoprotein Enhance Immunogenicity for Genetic ImmunizationJournal of Virology, 2002
- Evidence for Similar Recognition of the Conserved Neutralization Epitopes of Human Immunodeficiency Virus Type 1 Envelope gp120 in Humans and MacaquesJournal of Virology, 2001
- Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccineVaccine, 2000
- Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA VaccineScience, 1998